AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
31.83
-2.54 (-7.39%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Company Description

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.

The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation.

It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula’s to support access for EPi-Sense catheters.

In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel.

The company was incorporated in 2000 and is headquartered in Mason, Ohio.

AtriCure, Inc.
AtriCure logo
Country United States
Founded 2000
IPO Date Aug 5, 2005
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 1,300
CEO Michael Carrel

Contact Details

Address:
7555 Innovation Way
Mason, Ohio 45040
United States
Phone 513 755 4100
Website atricure.com

Stock Details

Ticker Symbol ATRC
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001323885
CUSIP Number 04963C209
ISIN Number US04963C2098
Employer ID 34-1940305
SIC Code 3841

Key Executives

Name Position
Michael H. Carrel Chief Executive Officer, President and Director
Angela L. Wirick Chief Financial Officer
Douglas J. Seith Chief Operating Officer
Salvatore Privitera J.D. Chief Technical Officer
Karl S. Dahlquist CCEP, J.D. Chief Legal Officer
Dr. Vinayak Doraiswamy Ph.D. Chief Scientific Officer
Valerie Storch-Willhaus Vice President of Corporate Marketing and Communications
Justin J. Noznesky Chief Marketing and Strategy Officer
Deborah Yount Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Mar 26, 2025 8-K Current Report
Mar 5, 2025 144 Filing
Feb 14, 2025 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 14, 2025 10-K Annual Report
Feb 14, 2025 SCHEDULE 13G/A Filing
Feb 12, 2025 8-K Current Report
Jan 13, 2025 8-K Current Report
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SCHEDULE 13G Filing
Oct 30, 2024 10-Q Quarterly Report